Objective: To investigate the in vivo role of the IRE1/XBP1 unfolded protein response (UPR) signaling pathway in cartilage. Design: Xbp1 flox/flox .Col2a1-Cre mice (Xbp1
Introduction
Endochondral ossification is regulated in the cartilage growth plate, where chondrocytes secrete an elaborate extracellular matrix (ECM) and differentiate by proliferation and hypertrophy to drive longitudinal bone growth. Owing to the burden placed on the endoplasmic reticulum (ER) by the production of cartilage ECM components, chondrocytes rely on the unfolded protein response (UPR) to maintain ER homeostasis 1, 2 .
The UPR is regulated by ER membrane-spanning proteins including IRE1, ATF6, and PERK. These ER stress sensors reduce ER protein load by activating molecular pathways that increase the capacity of the ER to fold nascent proteins correctly and to eradicate chronically misfolded proteins, and reduce the overall rate of protein translation 3 . Several other ER sensors that are structurally and functionally homologous to ATF6 have also been described 1 . For cartilage development, the most important of these appears to be BBF2H7. Deletion of Bbf2h7 causes a severe chondrodysplasia resulting from chondrocyte ER stress caused by impaired intracellular trafficking of secreted proteins 2 . Also important is ATF4, a transcription factor expressed following ER stress-induced activation of PERK. ATF4 controls chondrocyte proliferation and growth plate mineralization by regulating expression of IHH, and like BBF2H7 its ablation results in a dramatic chondrodysplasia 4 . Together these studies emphasize the importance of chondrocyte ER homeostasis for cartilage development. IRE1 signaling in cartilage development in vivo has not been investigated. IRE1 activation by ER stress results in the unconventional splicing of XBP1 mRNA to encode a transcription factor that drives the expression of UPR target genes. IRE1 also acts independently of XBP1 in a rapid response to ER stress known as regulated IRE1-dependent decay (RIDD), degrading a subset of transcripts encoding proteins normally processed via the ER 5 . XBP1 regulates several developmental processes involving professional secretory cells 6 , and may also regulate cartilage development 7 . It was reported recently that spliced XBP1 (XBP1 S ) was expressed in the mouse growth plate and during chondrogenic differentiation in vitro. Moreover, over-expression of XBP1 S in these studies accelerated chondrocyte hypertrophy and the expression of Ihh, Col10a1, and Runx2, as well as Pthrp, while knockdown abolished hypertrophy and the expression of these genes. These data suggested that XBP1 may be required for chondrocyte hypertrophy by affecting IHH/PTHrP signaling and acting as a co-factor of RUNX2 7 .
To determine if the XBP1 pathway controls chondrocyte hypertrophy in vivo we generated and characterized mice in which XBP1 was functionally inactivated by deletion of exon 2 in cartilage (Xbp1
CartDEx2 ). We demonstrate that cartilage-specific ablation of XBP1 activity does not prevent chondrocyte hypertrophy in vivo, in contrast to predictions from in vitro data 7 , but causes a chondrodysplasia phenotype involving shortening of endochondral bones and delayed endochondral ossification during development, but which resolves by skeletal maturity. Moreover Xbp1 CartDEx2 growth plates are marked by shortening of the growth plate hypertrophic zone and dysregulated chondrocyte proliferation. This is the first study to implicate the IRE1/XBP1 signaling pathway in cartilage development in vivo, and suggests hitherto unknown physiological functions for IRE1/XBP1 signaling in development. 
Methods

Generation of mice with cartilage-specific Xbp1 inactivation
Skeletal preparations and morphometry
Mouse skeletons were analyzed morphometrically following Alcian blue and Alizarin red staining as described 11 . Femoral and tibial lengths were used to indicate endochondral bone growth, and intercanthal distance (ICD) to measure intramembranous bone growth 12 . X-ray images were prepared as described 12 .
Immunofluorescence and histology
Immunofluorescence and histology was performed on PFA-fixed 10 mm cryosections or 5 mm paraffin-embedded sections of proximal tibial epiphyses from Xbp1 CartDEx2 or wildtype mice. Immunofluorescence was performed using mouse anti-mouse collagen II (6B3, Neomarkers) rabbit anti-human collagen X, or rabbit antihuman IHH (EP1192Y, Abcam) and appropriate fluorescent secondary antibodies (10 mg/ml; Molecular Probes, Life Technologies).
Rabbit polyclonal collagen X antibodies were produced using His 6 -tagged full length human collagen X cDNA purified from transfected 293-EBNA cells 13 . Prior to antigen retrieval, all sections were incubated for 10 min at room temperature in PBS, 0.2% Triton X-100 (SigmaeAldrich). For collagen II antigen retrieval, sections were digested for 10e15 min at 37 C in 2 mg/ml porcine pepsin (Sigma Aldrich). For collagen X antigen retrieval, sections were digested for 10e15 min at 37 C in 2 mg/ml bovine hyaluronidase (Sigma Aldrich). Collagen II staining was performed using reagents from the VECTOR M.O.M. Immunodetection Basic Kit (Vector Laboratories, Inc). All immunofluorescence sections were counterstained and mounted using VECTASHIELD Mounting Medium with DAPI (Vector Laboratories, Inc), and visualized using an Axio Imager M1 fluorescent microscope (Zeiss). Hematoxylin and eosin (H&E) staining was performed following a standard protocol involving staining in hematoxylin for 5 min and eosin for 1 min. Toluidine blue staining was performed using a standard protocol involving 10 min immersion in Toluidine blue and a 3 min counterstain in Fast Green. Staining for tissue mineralization was performed using standard protocols for Alizarin Red or Von Kossa stains.
Cell death and proliferation assays
Bromodeoxyuridine (BrdU) labeling analysis was performed by injecting Cell Proliferation Labeling Reagent (Amersham) peritoneally to detect growth plate chondrocyte proliferation 14 . Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was performed with the In Situ Cell Death Detection Kit, Fluorescein (Roche) to detect DNA fragmentation in cells undergoing programmed cell death 14 .
Primary chondrocyte cultures
Primary chondrocytes from femoral and tibial condyles of 3 day old Xbp1
CartDEx2 mice were isolated as described 15 and cultured overnight at a concentration of approximately 1.0 Â 10 5 cells/cm 2 in Dulbecco's modified Eagle's medium (DMEM), 10% fetal bovine serum (Thermo Fisher Scientific) supplemented with 1 mg/ml penicillin and 0.1 mg/ml streptomycin (Sigma Aldrich) at 37 C under 95% air, 5% CO 2 . Media was replaced the following day with fresh media, with or without 2.5 ng/ml tunicamycin (Sigma Aldrich), and cultures were incubated for a further 4 h. RNA was extracted using the RNeasy Mini Kit (Qiagen).
Microdissection of growth plate zones, RNA isolation and amplification
Growth plate zones were microdissected from one proximal tibial growth plate from each of three 2 week old Xbp1
CartDEx2 and wildtype mice as described previously 16 . RNA was extracted from microdissected tissues using TRIzol reagent (Invitrogen). All total RNA samples were subjected to two rounds of linear amplification using the RNA ampULSe Amplification Kit (Kreatech). We have previously validated that this method preserves the relative abundance of transcripts present in cartilage total RNA samples 16e18 . Purity and integrity of all RNA samples were validated by electrophoresis with a 2200 TapeStation using a High Sensitivity R6K Screen Tape Kit (Agilent Technologies).
Quantitative PCR (qPCR) analysis
For Xbp1 splicing, RT-PCR was performed on equal quantities of cDNA using primers flanking the ER stress-responsive Xbp1 splice site. qPCR was performed on equal quantities of cDNA using the LightCycler 480 Probes Master Kit on a LightCycler 480 II qPCR machine (Roche Applied Science) as described 16 . All primer sequences are available on request.
Statistical methods
All quantitative data were generated using biological replicates in triplicate, unless stated otherwise, and are expressed as the mean plus 95% confidence interval. In each case, P values were determined using the unpaired Student's t test. All analyses were conducted using GraphPad QuickCalcs software (La Jolla, CA, USA).
Results
Xbp1
CartDEx2 mice exhibit mild dwarfism and delayed ossification
RT-PCR analysis and sequencing confirmed deletion of exon 2 from Xbp1 mRNA in Xbp1
CartDEx2 but not wildtype cartilages Fig. 2(A),(B) ]. Hypertrophic zone shortening was confirmed by collagen X immunofluorescence in adult [ Fig. 2 (E),(F)] and embryonic tissues [ Fig. 2(R),(S) ]. Growth plate zone lengths were also quantified in 2 week old mice using H&E-stained tissues. This revealed an approximately 45% reduction in hypertrophic zone length and a modest reduction in resting zone length in Xbp1 CartDEx2 vs wildtype at 2 weeks of age [ Fig. 2(G) ]; no differences were apparent in growth plate zone length between wildtype and mutant at 7 weeks of age ( Fig. S1(B) ). Delayed mineralization of Xbp1 CartDEx2 endochondral bones during development was confirmed in 2 week old [ Fig. 2(H , and Ihh, which regulates chondrocyte proliferation from its site of expression in the hypertrophic zone 24 [ Fig. 4(A) 
IRE1 is hyperactivated in the Xbp1
CartDEx2 growth plate, we investigated Xbp1 splicing in Xbp1 CartDEx2 and wildtype growth plate zones [ Fig. 6(A) ]. In the wildtype proliferative zone, most Xbp1 transcripts were Xbp1 U , however low levels of Xbp1 S were also detectable. In the wildtype hypertrophic zone, only Xbp1 U transcripts were detectable. In Xbp1
CartDEx2
, most Xbp1 transcripts in both zones were Xbp1 S , confirming in vivo hyperactivation of IRE1 in Xbp1
CartDEx2 chondrocytes.
To determine whether IRE1 hyperactivation induces RIDD, we assayed RIDD by qPCR using four established mammalian RIDD marker genes 5 in the hypertrophic zone, we could not detect depletion of any of the transcripts in either growth plate zone from Xbp1
CartDEx2 compared with the corresponding zone from wildtype. Thus, while Xbp1 CartDEx2 chondrocytes can induce RIDD, they appear not to do so as a consequence of IRE1 hyperactivation. Therefore, we could exclude RIDD-mediated dysregulation of growth plate gene expression as a factor contributing to the Xbp1 CartDEx2 phenotype.
Discussion
We analyzed Xbp1 CartDEx2 mice, in which XBP1 activity is ablated from cartilage. Previous studies involving differentiation of chondrogenic cell lines in vitro suggested an essential role for XBP1 in controlling chondrocyte hypertrophy by acting co-ordinately with RUNX2 and regulating Pthrp, Ihh, Runx2, Col2a1, and Col10a1 expression 7 . Our studies show that in the more complex situation of cartilage development in vivo, XBP1 is not required for chondrocyte hypertrophy. Nevertheless, Xbp1
CartDEx2 exhibits a chondrodysplasia during skeletal development involving disorganized proliferative zone architecture, hypertrophic zone shortening, and delayed mineralization of endochondral bones.
Although we could not detect a significant difference between the length of the proliferative zone in Xbp1
CartDEx2 and wildtype, the chondrocyte columns of the proliferative zone were significantly longer in the mutant than in wildtype at 2 weeks of age, hinting at a role for the XBP1 pathway in chondrocyte proliferation. This was confirmed by BrdU analysis showing mild impairment of chondrocyte proliferation in the Xbp1 CartDEx2 growth plate. PTHrP inhibits chondrocyte differentiation and promotes chondrocyte proliferation in the growth plate in a feedback loop involving IHH 24 . Thus, defective IHH/PTHrP signaling could explain the reduced chondrocyte proliferation we observed in the Xbp1
CartDEx2 growth plate. However, differential expression consistent with reduced chondrocyte proliferation was not detected for key markers of this process, including IHH. The only chondrocyte proliferation marker found to be significantly differentially expressed was Ccnd1, which appeared to be modestly upregulated in the mutant proliferative zone. Previous work however, suggests that increased expression of Ccnd1 in chondrocytes promotes, rather than inhibits their proliferation 22 . Alternatively, our data may point to a role for XBP1 in regulating the activity of integrins or integrin-linked kinase, since disruption to integrin-dependent interactions between chondrocytes and the growth plate matrix are known to result in chondrodysplasias characterized by disrupted proliferative zone architecture 27, 28 , and can upregulate UPR target genes in response to ER stress 31 . The significance of Luman upregulation in Xbp1 CartDEx2 chondrocytes is unclear. Our work implies however, that it does not depend on classical ER stress. Rather, Luman expression may be induced by IRE1 in an XBP1-independent manner following either ER stress or IRE1 hyperactivation.
The chondrodysplasia in Xbp1 CartDEx2 mice is mild, involving a generalized delay in endochondral ossification rather than the complete blockage in chondrocyte hypertrophy predicted by recent in vitro studies 7 . Indeed, by 7 weeks of age no difference was apparent between wildtype and Xbp1
CartDEx2 in terms of the length of endochondral bones or growth plate morphology. This implies a role for XBP1 in regulating the timing of endochondral ossification rather than directing chondrocyte differentiation per se. In contrast, the dwarfism phenotype is severe in both the Bbf2h7 and Atf4 null mice, due to disrupted protein trafficking and IHH signaling, respectively 2,4 . These differences highlight how endochondral ossification may be regulated by components of ER stressresponsive pathways through a variety of mechanisms. Finally, we note that activation of XBP1 signaling has been reported as a component of the pathological destruction of cartilage in human and animal models of osteoarthritis (OA) 32, 33 , a disease characterized by re-activation of chondrocyte proliferation, differentiation and hypertrophy programs 34 . Our work provides links between XBP1 and each of these aspects of chondrocyte biology in vivo, by implying that it promotes chondrocyte proliferation and regulates the timing of cartilage maturation and biomineralization. Future studies will address the role of the XBP1 pathway in the pathology of OA by investigating the progression of joint pathology in Xbp1
CartDEx2 mice following destabilization of the medial meniscus.
In conclusion, we have demonstrated that XBP1 regulates chondrocyte proliferation and the timing of cartilage maturation and matrix mineralization during endochondral ossification. This study is the first to analyze the function of XBP1 in growth plate cartilage, and extends our understanding of how key UPR components interact with molecular pathways controlling physiological development.
